NHIC

NewHold Investment Corp. III
3 filings tracked
energynuclear energyMICRO (<$300M)

Signal Magnitude Chart

BEARISH | 70% | 5/18/2026 | margin compressionBULLISH | 60% | 5/18/2026 | earnings beatNEUTRAL | 30% | 5/18/2026 | management changeBULLISH | 90% | 5/27/2026 | acquisitionBULLISH | 80% | 5/27/2026 | capital raiseBEARISH | 60% | 5/27/2026 | dilution riskBULLISH | 70% | 5/28/2026 | acquisitionBEARISH | 60% | 5/28/2026 | dilution riskMay 26May 26HIGHLOW
bullish
bearish
neutral

Signal Timeline

bullishMay 28

Strategic merger with NewCleo to enter the advanced nuclear reactor market.

acquisition
70%
bearishMay 28

Potential for significant shareholder redemptions to deplete cash reserves.

dilution risk
60%
bullishMay 27

Definitive business combination agreement signed with NewCleo Ltd.

acquisition
90%
bullishMay 27

Secured $220 million via PIPE investment at $10.00 per share.

capital raise
80%
bearishMay 27

Complex recapitalization factor and potential for mass redemptions.

dilution risk
60%
bearishMay 18

G&A expenses surged 330% year-over-year to $1.15 million.

margin compression
70%
bullishMay 18

Net income increased to $704,000 driven by trust interest income.

earnings beat
60%
neutralMay 18

Management issued a formal going-concern warning regarding the March 2027 deadline.

management change
30%

Filing History

8-KMay 28, 2026

The 8-K filing confirms a complex two-step merger designed to bring NewCleo's advanced nuclear technology to the public markets. While the deal offers a high-reward path for investors betting on a nuclear renaissance, it carries the classic risks of a deSPAC transaction, including potential liquidity crises and extreme technical execution risk. The ultimate success of the venture depends on the company's ability to secure institutional backing and navigate the rigorous regulatory landscape for nuclear energy without exhausting its initial capital pool.

8-KMay 27, 2026

The filing signals a high-stakes transition for NewCleo as it moves toward a Nasdaq listing via NewHold Investment Corp III. While the $2.35 billion valuation and $220 million PIPE provide a strong starting point for growth, the deal's success hinges on the upcoming shareholder vote and the ability to maintain a minimum cash floor. Investors should view this as a binary event where the primary risk is not the underlying business of NewCleo, but the structural integrity of the SPAC merger and the resulting capital position upon closing.

10-QMay 18, 2026

The Q1 2026 filing for NewHold Investment Corp III presents a stark contrast between the stability of its trust assets and the volatility of its operating expenses. While the trust's growth to $211 million provides a tangible safety net for public shareholders, the company's internal financial health is strained, as evidenced by the formal going-concern disclosure. The tension lies in whether the increased spending on target identification will result in a timely merger before the March 2027 deadline. Ultimately, the investment case hinges on the management team's ability to convert their current search activity into a viable business combination. Investors are essentially holding a leveraged call option on the team's execution capability, backed by a cash-equivalent floor. The critical path forward will be the announcement of a target and the subsequent redemption rate, which will determine if the company has sufficient firepower to finalize a transaction of meaningful scale.